Patrick Breheny

Patrick Breheny

University of Iowa

H-index: 37

North America-United States

About Patrick Breheny

Patrick Breheny, With an exceptional h-index of 37 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Iowa, specializes in the field of High-dimensional statistics, penalized likelihood models, computational statistics, genomics/genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cross-validation approaches for penalized Cox regression

Fluid shear stress enhances metastatic potential and rapidly alters metabolism of circulating tumor cells

Package ‘ncvreg’

Surgical management of G3 gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis

CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression

Feature‐specific inference for penalized regression using local false discovery rates

CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors

Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors

Patrick Breheny Information

University

Position

Professor of Biostatistics

Citations(all)

5874

Citations(since 2020)

3825

Cited By

3543

hIndex(all)

37

hIndex(since 2020)

29

i10Index(all)

69

i10Index(since 2020)

62

Email

University Profile Page

Google Scholar

Patrick Breheny Skills & Research Interests

High-dimensional statistics

penalized likelihood models

computational statistics

genomics/genetics

Top articles of Patrick Breheny

Title

Journal

Author(s)

Publication Date

Cross-validation approaches for penalized Cox regression

arXiv preprint arXiv:1905.10432

Biyue Dai

Patrick Breheny

2019/5/24

Fluid shear stress enhances metastatic potential and rapidly alters metabolism of circulating tumor cells

Cancer Research

Devon L Moose

Amanda N Pope

Marion Dykstra

Eric B Taylor

Patrick Breheny

...

2024/3/22

Package ‘ncvreg’

Patrick Breheny

Maintainer Patrick Breheny

2023/4/3

Surgical management of G3 gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis

Ioannis A Ziogas

Panagiotis T Tasoudis

Luis C Borbon

Scott K Sherman

Patrick J Breheny

...

2023/1

CDK4/6-MEK inhibition in MPNSTs causes plasma cell infiltration, sensitization to PD-L1 blockade, and tumor regression

Clinical cancer research

Jordan L Kohlmeyer

Joshua J Lingo

Courtney A Kaemmer

Amanda Scherer

Akshaya Warrier

...

2023/9/1

Feature‐specific inference for penalized regression using local false discovery rates

Statistics in Medicine

Ryan Miller

Patrick Breheny

2023/4/30

CDK4/6-MEK Targeted Therapy Causes Regression and Reduced Metastatic Colonization of Pancreatic Neuroendocrine Tumors

Endocrine Abstracts

Courtney Kaemmer

Shaikamjad Umesalma

Chandra Maharjan

Jordan Kohlmeyer

Emily Wilkerson

...

2023/2/1

Therapies targeting CDK4/6 cause regression, immune cell activation, and sensitization to PD-L1 immunotherapy in pancreatic neuroendocrine tumors

Endocrine Abstracts

Courtney Kaemmer

Shaikamjad Umesalma

Chandra Maharjan

Jordan Kohlmeyer

Joshua Lingo

...

2023/12/15

Abstract B047: Fluid shear stress enhances the metastatic potential and rapidly alters metabolism of circulating tumor cells

Cancer Research

Devon L Moose

Amanda N Pope

Marion Vanneste

Patrick Breheny

Eric B Taylor

...

2023/1/15

Peptide receptor radionuclide therapy improves survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors

Endocrine Abstracts

Luis C Borbon

Scott K Sherman

Patrick Breheny

Po H Ear

Yusuf Menda

...

2023/12/15

ASO Visual Abstract: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms—A Systematic Review and Meta-Analysis

Ioannis A Ziogas

Panagiotis T Tasoudis

Luis C Borbon

Scott K Sherman

Patrick J Breheny

...

2023

Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targets

The Journal of steroid biochemistry and molecular biology

Kristina W Thiel

Andreea M Newtson

Eric J Devor

Yuping Zhang

Paige K Malmrose

...

2023/11/1

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo

Neuro-oncology advances

Jordan L Kohlmeyer

Courtney A Kaemmer

Joshua J Lingo

Ellen Voigt

Mariah R Leidinger

...

2022/1/1

Metabolic differences among newborns born to mothers with a history of leukemia or lymphoma

The journal of maternal-fetal & neonatal medicine

Sonia T Anand

Kelli K Ryckman

Rebecca J Baer

Mary E Charlton

Patrick J Breheny

...

2022/12/12

The risk of preterm birth among women with a history of leukemia or lymphoma

The journal of maternal-fetal & neonatal medicine

Sonia T Anand

Elizabeth A Chrischilles

Rebecca J Baer

Mary E Charlton

Patrick J Breheny

...

2022/12/12

Hypertensive disorders of pregnancy among women with a history of leukemia or lymphoma

Pregnancy hypertension

Sonia T Anand

Kelli K Ryckman

Rebecca J Baer

Mary E Charlton

Patrick J Breheny

...

2022/8/1

Adaptive hybrid screening for efficient lasso optimization

Journal of Statistical Computation and Simulation

Chuyi Wang

Patrick Breheny

2022/7/24

Prognostic and therapeutic value of the Hippo pathway, RABL6A, and p53-MDM2 axes in sarcomas

Oncotarget

Chandni Desai

Jon Thomason

Jordan L Kohlmeyer

Anna C Reisetter

Parmanand Ahirwar

...

2021/4/4

Perinatal determinants of growth trajectories in children born preterm

PLoS One

Elizabeth A Jasper

Hyunkeun Cho

Patrick J Breheny

Wei Bao

John M Dagle

...

2021/1/28

Penalized linear mixed models for structured genetic data

Anna C Reisetter

Patrick Breheny

2021/7

See List of Professors in Patrick Breheny University(University of Iowa)

Co-Authors

academic-engine